School of Medicine
Showing 21-40 of 82 Results
-
Jeremy Goldhaber-Fiebert
Professor of Health Policy
BioJeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy and a Core Faculty Member in the Centers for Health Policy and Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021.
Past and current research topics:
- Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.
-Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.
- Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.
- Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.
- Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity. -
Mary Kane Goldstein
Professor of Health Policy, Emerita
Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities
-
Steven Goodman
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsI am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.
-
Anna H Grummon
Assistant Professor of Pediatrics (General Pediatrics) and, by courtesy, of Health Policy
BioDr. Grummon is an Assistant Professor of Pediatrics and (by courtesy) Health Policy and the Director of the Stanford Food Policy Lab. Dr. Grummon is a behavioral scientist whose work seeks to identify and evaluate policies that encourage healthy eating and help children and their families live long, healthy lives. In her work, Dr. Grummon uses randomized trials, natural experiments, and simulation modeling to examine how food policies like warning labels, beverage taxes, and food assistance programs affect what we eat and how healthy we are. She also studies strategies for encouraging people to choose foods that are more environmentally sustainable. Dr. Grummon's program of research has been funded by the National Institutes of Health, the Robert Wood Johnson Foundation, the New York City Department of Health and Mental Hygiene, and others. Her work has been published in leading medical and public health journals including JAMA, New England Journal of Medicine, Science, and the American Journal of Public Health and received coverage in news outlets such as the Washington Post, NBC, NPR, and Forbes.
Dr. Grummon holds a PhD and MSPH in Health Behavior from the University of North Carolina Gillings School of Global Public Health and a BA with Honors in Human Biology from Stanford. She completed her postdoctoral training at Harvard. -
Mark Hlatky, MD
Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
On Partial Leave from 09/01/2023 To 08/31/2024Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.
-
Bob Kocher
Adjunct Professor, Health Policy
BioBob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Sitka, Need, Accompany Health, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company and previously Included Health (Grand Rounds + Doctor on Demand) and Castlight.
He is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM).
Previously, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council, as a Partner at McKinsey & Company, and is an internal medicine doctor.